After about a month of human growth hormone, a healthy 46-year-old showed MRI signs that their aging immune gland had partly reversed.
See the scientific wording
In a single healthy 46-year-old human subject, approximately one month of human growth hormone administration was followed by MRI evidence consistent with partial reversal of established age-related thymic involution; the authors describe this as the first such demonstration in a normal human subject. No dose, absolute effect size, or relative effect size was reported.
Indication only — weak evidence
One low-scoring study points this way, but the evidence is still early.
What the research says
1 study reviewedSupporting (1)
Apparent Induction of Partial Thymic Regeneration in a Normal Human Subject: A Case Report
Case ReportHuman2003
The abstract states that the observations apparently provide the first demonstration of growth hormone-induced partial reversal of established thymic involution in a normal human subject. This directly supports a descriptive claim about what the authors reported, while the single-case design limits any general conclusion.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
A person received a growth hormone shot for about a month. The shot raised growth hormone in the blood. This made the body produce more IGF-1, a chemical signal that tells cells to grow and survive. IGF-1 traveled to the thymus, an organ behind the breastbone that helps train immune cells. In older people, the thymus shrinks. IGF-1 told the thymus cells to multiply and stay alive, so the working part of the thymus grew larger. MRI scans showed more working thymus tissue, meaning the thymus partly grew back.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
After about a month of human growth hormone, a healthy 46-year-old showed MRI signs that their aging immune gland had partly reversed.
Mechanism
1 studyA growth hormone shot made the body produce more IGF-1, a growth signal. That signal told the thymus, an immune organ that shrinks with age, to make more of its working cells. The thymus grew back partly, and MRI showed more working tissue. This is the best explanation because IGF-1 rose and the thymus got bigger, but it is based on one person, so the full chain is not proven.
A person received a growth hormone shot for about a month. The shot raised growth hormone in the blood. This made the body produce more IGF-1, a chemical signal that tells cells to grow and survive. IGF-1 traveled to the thymus, an organ behind the breastbone that helps train immune cells. In older people, the thymus shrinks. IGF-1 told the thymus cells to multiply and stay alive, so the working part of the thymus grew larger. MRI scans showed more working thymus tissue, meaning the thymus partly grew back.
Recombinant human growth hormone is administered and enters the bloodstream, raising circulating growth hormone levels, which stimulates production of insulin-like growth factor 1 (IGF-1) in the liver and other tissues.
Circulating IGF-1 levels rise and reach the upper range of normal for young adults.
IGF-1 binds to receptors on thymic epithelial cells and thymocytes, activating intracellular signaling pathways that promote cell proliferation and survival, increasing the number of thymic cells.
The increased number of thymic epithelial cells and thymocytes expands functional thymic mass, restoring thymic architecture and partially reversing age-related thymic involution.
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Human Growth Hormone Effects on Thymic Volume and Involution
Systematic search and meta-analysis of randomized and controlled trials in healthy or aging adults that administer human growth hormone for at least one month and measure thymic volume or function by MRI or CT, comparing human growth hormone with placebo or no treatment, with prespecified outcomes of thymic involution reversal.
Randomized Controlled Trial of One-Month Human Growth Hormone vs Placebo for Thymic Involution in Healthy Adults
Double-blind randomized controlled trial in healthy adults aged 40-60 with established age-related thymic involution; randomize to human growth hormone at a defined dose or placebo for approximately one month; primary outcome is change in thymic volume or function by MRI; compare between groups.
Prospective Cohort Study of Human Growth Hormone-Treated Adults and Serial Thymic MRI Changes
Prospective cohort of healthy adults receiving clinically indicated human growth hormone or matched untreated controls; serial MRI thymic assessment at baseline and approximately one month; adjust for age, sex, and baseline thymic volume.
Case-Control Study Comparing Thymic MRI Findings in Human Growth Hormone-Exposed vs Unexposed Healthy Adults
Identify adults exposed to approximately one month of human growth hormone and matched unexposed controls; compare MRI evidence of partial reversal of age-related thymic involution; measure thymic volume and attenuation.
Structured Case Report of Serial MRI Thymic Changes After One Month of Human Growth Hormone in a Healthy 46-Year-Old
Detailed single-subject case report with baseline and post-human-growth-hormone MRI, standardized thymic volume or function measurement, independent radiology review, and full reporting of dose, duration, and adverse events.